Marketable Securities, Current in USD of IGC Pharma, Inc. from Q1 2020 to Q1 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of investment in marketable security, classified as current.
Summary
IGC Pharma, Inc. quarterly Marketable Securities, Current history and change rate from Q1 2020 to Q1 2023.
  • IGC Pharma, Inc. Marketable Securities, Current for the quarter ending 31 Mar 2023 was $154K.
Marketable Securities, Current, Quarterly (USD)
Marketable Securities, Current, YoY Quarterly Change (%)

IGC Pharma, Inc. Quarterly Marketable Securities, Current (USD)

Period Value YoY Chg Change % Date Report Filed
Q1 2023 $154K +$154K 31 Mar 2023 10-K 07 Jul 2023
Q2 2022 $0 $0 30 Jun 2022 10-Q 05 Aug 2022
Q1 2022 $0 $0 31 Mar 2022 10-K 07 Jul 2023
Q4 2021 $0 31 Dec 2021 10-Q 10 Feb 2022
Q3 2021 $0 30 Sep 2021 10-Q 29 Oct 2021
Q2 2021 $0 30 Jun 2021 10-Q 11 Aug 2021
Q1 2021 $0 -$5.08M -100% 31 Mar 2021 10-K 23 Jun 2022
Q1 2020 $5.08M 31 Mar 2020 10-K 14 Jun 2021
* An asterisk sign (*) next to the value indicates that the value is likely invalid.